Prof. Aurelija Žvirblienė, head of the Immunology Department at Vilnius University’s Life Sciences Center (LSC), together with her team, has developed hundreds of unique antibodies targeting viral and bacterial proteins, recombinant cytokines, cell receptors, and allergens.

Scientists from Vilnius University’s Life Sciences Center (VU LSC), in collaboration with colleagues from the University of Veterinary Medicine in Vienna and partners in French Guiana, are currently on an expedition to the Amazon rainforest, where they are studying the effects of climate change on amphibians.

An international summer school titled “Human Health and Environment by the Baltic Sea” will take place on August 11–15, 2025, on Seili Island (Finland). This summer school offers an excellent opportunity to deepen your knowledge in the fields of human health and environmental issues in the Baltic Sea region, working alongside students and lecturers from six well-known universities across the Nordic and Baltic countries.

Vilnius University’s Life Sciences Center (LSC) and two companies – Caszyme and nSAGE – have launched a collaborative project titled E! Universal CRISPR-Based Diagnostic Platform (UNCOVER). The aim of this project is to develop a CRISPR-Cas-based diagnostic platform capable of rapidly and accurately detecting infectious diseases.

Justas Vaitekūnas has defended his thesis entitled "Enzymatic Degradation of Pyridine and Pyridinols " for the degree of Doctor of Science in Biochemistry.

Marking the 50th anniversary of biotechnology science in Lithuania, students of the Vilnius University (VU) Life Sciences Center (LSC) received an exceptional gift – Thermo Fisher Scientific Baltics donated cutting-edge research equipment and reagents worth €0.5 million. VU representatives emphasize that this is not just an investment in laboratories, but in the next generation of scientists who will develop tomorrow’s scientific solutions.

The traditional "Three Minute Thesis" (3MT) competition took place at Vilnius University's (VU) Scholarly Communication and Information Centre Conference Hall. A total of 15 PhD students competed, and the jury awarded the first place to Indrė Lapinskienė, a PhD student from the VU Faculty of Medicine. The second place went to Gerda Jasinevičienė from the Life Sciences Center (LSC), while the third place was awarded to Jonas Žurauskas from the Faculty of Chemistry and Geosciences (CHGE).

Kristina Žukauskaitė has defended her thesis entitled "Impact of Gastrointestinal Cancer Therapies on the Gut Microbiome: Findings from Clinical Studies and an In Vitro Modelling" for the degree of Doctor of Science in Biology.

On February 25, the VU Life Sciences Center (LSC) was visited by representatives of the University of Greifswald: Rector of the University, Prof. Katharina Riedel, Head of the Interdisciplinary Centre for Baltic Sea Region Research (IFZO), Dr. Alexander Drost, and Coordinator of the DAAD Project "Teaching Internationally," Thomas Jenssen.

Groundbreaking development of single-cell -omics tools by Vilnius University (VU) Life Sciences Center (LSC) scientists – Dr Greta Leonavičienė and Prof. Linas Mažutis – has paved the way for advancements in biotechnology. Their research have led to a $25 million Series A investment in the biotech startup "Atrandi Biosciences."

"When the people you've admired on stage for years listen to your lecture... when you get to step behind the scenes, feel the theater’s magic, and be surrounded by its muses… it’s like a dream!" – this is how Dr. Eglė Lastauskienė, a researcher at Vilnius University Life Sciences Center, describes her experience working with actors. She was invited to consult the Lithuanian National Drama Theatre troupe as they prepared for the premiere of "Fermentacija" – a play about an unusual biological revolution where microorganisms challenge humans.

Martyna Koplūnaitė has defended her thesis entitled "Chemoenzymatic synthesis of nucleoside 5'-monophosphates" for the degree of Doctor of Science in Biochemistry.

As cancer diagnostics continue to evolve, the ability to detect and treat the disease at an early stage is improving significantly. One of the recent groundbreaking innovations is liquid biopsy – a method that detects genetic mutations without invasive procedures. Alongside this, genetic and epigenetic research is increasingly critical in advancing cancer diagnostics and treatment.